Galderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies are responding to increased demand linked to the popularity of GLP-1 obesity drugs. Experts indicate that rapid weight loss may lead to skin laxity and diminished facial volume. While existing treatments show promise, some limitations remain in addressing deeper facial structure issues.
RSS News
Economic times
0 thoughts on “Beauty firms chase 'Ozempic face' market as weight-loss drugs boom”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- ‘Finding a place to belong’: Sonia Gandhi makes Instagram debut, shares first look of memoir
- SIR gathers pace on second day as over 54.68 lakh enumeration forms distributed across Karnataka
- A Mangaluru doctor dated a fellow doctor for 7 years, they split over caste differences, she filed a case accusing him of sex on false promise of marriage; Karnataka HC quashes case, says a consensual relationship turning sour is not a false promise of marriage
- The SCO’s credibility depends on consistent action against terror | The Hindu Editorial
- INDIA bloc huddle: Leaders to meet virtually on CEC row; SIR irregularities on agenda
